 Xiaoli Yu
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 21 | 2026 | 487 | 6.600 |
Why?
| | Immunoglobulin G | 17 | 2026 | 887 | 3.910 |
Why?
| | Oligoclonal Bands | 8 | 2026 | 26 | 2.800 |
Why?
| | Epstein-Barr Virus Infections | 2 | 2023 | 101 | 1.300 |
Why?
| | Neurons | 7 | 2026 | 1644 | 1.270 |
Why?
| | Epitopes | 7 | 2020 | 473 | 1.130 |
Why?
| | Peptide Library | 8 | 2020 | 91 | 1.090 |
Why?
| | Plasma Cells | 6 | 2020 | 79 | 1.050 |
Why?
| | Herpesvirus 3, Human | 6 | 2020 | 341 | 1.020 |
Why?
| | Peptide Fragments | 3 | 2020 | 693 | 0.980 |
Why?
| | Virus Latency | 3 | 2020 | 90 | 0.980 |
Why?
| | Autoantibodies | 4 | 2020 | 1508 | 0.900 |
Why?
| | Central Nervous System | 1 | 2026 | 281 | 0.800 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2023 | 28 | 0.780 |
Why?
| | Extracellular Vesicles | 2 | 2022 | 169 | 0.740 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2023 | 82 | 0.740 |
Why?
| | Recombinant Proteins | 7 | 2020 | 1368 | 0.710 |
Why?
| | Demyelinating Diseases | 1 | 2022 | 84 | 0.700 |
Why?
| | Neuroblastoma | 1 | 2023 | 174 | 0.690 |
Why?
| | Laser Capture Microdissection | 1 | 2020 | 29 | 0.640 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 140 | 0.620 |
Why?
| | DNA, Viral | 2 | 2020 | 355 | 0.620 |
Why?
| | Glioblastoma | 1 | 2022 | 352 | 0.560 |
Why?
| | Bacteriophages | 1 | 2020 | 110 | 0.560 |
Why?
| | Apoptosis | 3 | 2023 | 2434 | 0.540 |
Why?
| | Peptides | 6 | 2022 | 997 | 0.520 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 361 | 0.500 |
Why?
| | Lymphocytes | 2 | 2017 | 376 | 0.470 |
Why?
| | Antibody Specificity | 3 | 2020 | 177 | 0.450 |
Why?
| | Amino Acid Sequence | 10 | 2020 | 2127 | 0.440 |
Why?
| | Molting | 3 | 2003 | 9 | 0.420 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 6 | 2023 | 847 | 0.400 |
Why?
| | Brain Neoplasms | 1 | 2022 | 1328 | 0.370 |
Why?
| | Virus Activation | 1 | 2012 | 94 | 0.360 |
Why?
| | Herpesvirus 4, Human | 3 | 2023 | 172 | 0.350 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2011 | 9 | 0.350 |
Why?
| | Antigens, Viral | 2 | 2011 | 182 | 0.350 |
Why?
| | Measles virus | 2 | 2009 | 21 | 0.350 |
Why?
| | Brain | 3 | 2020 | 2934 | 0.340 |
Why?
| | Gene Targeting | 1 | 2011 | 80 | 0.330 |
Why?
| | Bacteriophage M13 | 2 | 2007 | 10 | 0.320 |
Why?
| | Humans | 31 | 2026 | 145140 | 0.320 |
Why?
| | Neuromyelitis Optica | 2 | 2011 | 140 | 0.310 |
Why?
| | Cell Culture Techniques | 1 | 2012 | 372 | 0.310 |
Why?
| | Viral Proteins | 2 | 2013 | 350 | 0.290 |
Why?
| | Protein Interaction Mapping | 1 | 2007 | 105 | 0.250 |
Why?
| | Epitope Mapping | 1 | 2006 | 61 | 0.240 |
Why?
| | Nephropidae | 2 | 2003 | 3 | 0.240 |
Why?
| | Glycosylation | 1 | 2026 | 173 | 0.230 |
Why?
| | Protein Aggregates | 1 | 2026 | 84 | 0.230 |
Why?
| | Muscular Atrophy | 2 | 2003 | 87 | 0.220 |
Why?
| | Antibodies, Viral | 3 | 2020 | 673 | 0.220 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1039 | 0.210 |
Why?
| | Antibodies | 1 | 2005 | 397 | 0.200 |
Why?
| | Calpain | 1 | 2003 | 61 | 0.190 |
Why?
| | Invertebrate Hormones | 1 | 2002 | 2 | 0.180 |
Why?
| | Viral Envelope Proteins | 2 | 2020 | 98 | 0.170 |
Why?
| | Biomarkers | 2 | 2023 | 4282 | 0.170 |
Why?
| | Immunity | 1 | 2021 | 140 | 0.160 |
Why?
| | Epstein-Barr Virus Nuclear Antigens | 1 | 2020 | 12 | 0.160 |
Why?
| | Regeneration | 1 | 2002 | 197 | 0.160 |
Why?
| | Injections, Spinal | 1 | 2020 | 119 | 0.160 |
Why?
| | bcl-X Protein | 1 | 2020 | 45 | 0.160 |
Why?
| | Immediate-Early Proteins | 1 | 2020 | 46 | 0.150 |
Why?
| | Electron Transport Complex IV | 1 | 2020 | 61 | 0.150 |
Why?
| | Complement System Proteins | 1 | 2023 | 313 | 0.150 |
Why?
| | Molecular Sequence Data | 7 | 2011 | 2881 | 0.150 |
Why?
| | Organ Specificity | 1 | 2020 | 308 | 0.150 |
Why?
| | Caspase 3 | 1 | 2020 | 242 | 0.140 |
Why?
| | Proteomics | 1 | 2026 | 1185 | 0.140 |
Why?
| | B-Lymphocytes | 3 | 2022 | 866 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2020 | 239 | 0.140 |
Why?
| | Cell Line | 3 | 2020 | 2821 | 0.130 |
Why?
| | RNA, Messenger | 3 | 2020 | 2803 | 0.130 |
Why?
| | Subacute Sclerosing Panencephalitis | 2 | 2006 | 6 | 0.130 |
Why?
| | Autoantigens | 1 | 2020 | 427 | 0.130 |
Why?
| | Middle Aged | 7 | 2026 | 36126 | 0.120 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2588 | 0.120 |
Why?
| | Brain Injuries | 1 | 2021 | 507 | 0.120 |
Why?
| | Blood Proteins | 1 | 2017 | 238 | 0.110 |
Why?
| | Syndecan-1 | 3 | 2011 | 43 | 0.110 |
Why?
| | Case-Control Studies | 2 | 2021 | 3616 | 0.110 |
Why?
| | Fetus | 1 | 2020 | 804 | 0.110 |
Why?
| | Female | 9 | 2026 | 78636 | 0.110 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1713 | 0.110 |
Why?
| | Adult | 6 | 2026 | 40665 | 0.110 |
Why?
| | Fibroblasts | 1 | 2020 | 1022 | 0.100 |
Why?
| | Male | 7 | 2026 | 72664 | 0.100 |
Why?
| | Sequence Analysis, DNA | 3 | 2006 | 776 | 0.100 |
Why?
| | Cytokines | 1 | 2021 | 2048 | 0.100 |
Why?
| | Clone Cells | 2 | 2010 | 263 | 0.100 |
Why?
| | Animals | 9 | 2023 | 37952 | 0.100 |
Why?
| | Chickenpox | 1 | 2013 | 82 | 0.090 |
Why?
| | Sequence Alignment | 3 | 2010 | 362 | 0.090 |
Why?
| | Stroke | 1 | 2021 | 1270 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 337 | 0.090 |
Why?
| | Blotting, Western | 2 | 2005 | 1177 | 0.090 |
Why?
| | Central Nervous System Infections | 1 | 2011 | 35 | 0.090 |
Why?
| | Infant, Newborn | 1 | 2023 | 6435 | 0.080 |
Why?
| | Rats, Inbred F344 | 1 | 2011 | 268 | 0.080 |
Why?
| | Inflammation | 1 | 2022 | 2876 | 0.080 |
Why?
| | Fish Proteins | 1 | 2010 | 12 | 0.080 |
Why?
| | Lampreys | 1 | 2010 | 20 | 0.080 |
Why?
| | Integrin beta1 | 1 | 2010 | 33 | 0.080 |
Why?
| | Mice | 4 | 2023 | 18303 | 0.080 |
Why?
| | Virus Diseases | 1 | 2011 | 216 | 0.070 |
Why?
| | Herpes Zoster | 1 | 2012 | 318 | 0.070 |
Why?
| | Immunoglobulin Variable Region | 2 | 2007 | 80 | 0.070 |
Why?
| | Antibody-Producing Cells | 1 | 2007 | 29 | 0.070 |
Why?
| | Antigens, CD19 | 2 | 2007 | 128 | 0.070 |
Why?
| | Nucleocapsid Proteins | 1 | 2006 | 28 | 0.060 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2006 | 76 | 0.060 |
Why?
| | Signal Transduction | 1 | 2020 | 5208 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 977 | 0.060 |
Why?
| | Measles | 1 | 2006 | 46 | 0.060 |
Why?
| | Flow Cytometry | 2 | 2007 | 1159 | 0.060 |
Why?
| | Protein Binding | 1 | 2011 | 2235 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2012 | 2040 | 0.050 |
Why?
| | Escherichia coli | 1 | 2009 | 834 | 0.050 |
Why?
| | Proteoglycans | 1 | 2004 | 112 | 0.050 |
Why?
| | Ecdysteroids | 1 | 2002 | 1 | 0.050 |
Why?
| | Hemolymph | 1 | 2002 | 6 | 0.050 |
Why?
| | Polyubiquitin | 1 | 2002 | 8 | 0.050 |
Why?
| | Brachyura | 1 | 2002 | 4 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 273 | 0.050 |
Why?
| | Rats | 1 | 2011 | 5582 | 0.050 |
Why?
| | Base Sequence | 2 | 2003 | 2168 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2003 | 387 | 0.050 |
Why?
| | Cloning, Molecular | 1 | 2003 | 537 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1505 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2003 | 267 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2009 | 2504 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 499 | 0.040 |
Why?
| | Extremities | 1 | 2002 | 140 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1995 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2002 | 212 | 0.040 |
Why?
| | Time Factors | 1 | 2011 | 7107 | 0.040 |
Why?
| | Actins | 1 | 2002 | 424 | 0.040 |
Why?
| | DNA | 1 | 2006 | 1433 | 0.040 |
Why?
| | Phylogeny | 1 | 2003 | 917 | 0.040 |
Why?
| | Viral Plaque Assay | 1 | 2014 | 29 | 0.030 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 2013 | 16 | 0.020 |
Why?
| | Genes, Viral | 1 | 2013 | 88 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2013 | 155 | 0.020 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2013 | 93 | 0.020 |
Why?
| | Virus Assembly | 1 | 2013 | 81 | 0.020 |
Why?
| | Prognosis | 1 | 2021 | 4310 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2003 | 1789 | 0.020 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 68 | 0.020 |
Why?
| | Virus Replication | 1 | 2013 | 519 | 0.020 |
Why?
| | Granulocytes | 1 | 2010 | 81 | 0.020 |
Why?
| | B-Lymphocyte Subsets | 1 | 2009 | 76 | 0.020 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2006 | 43 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1261 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1300 | 0.010 |
Why?
| | Syndecans | 1 | 2004 | 5 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2004 | 86 | 0.010 |
Why?
| | Antigens, CD | 1 | 2006 | 558 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2002 | 156 | 0.010 |
Why?
| | Computational Biology | 1 | 2006 | 669 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2002 | 318 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2002 | 909 | 0.010 |
Why?
|
|
Yu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|